Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Temecula › NPI 1912522723
Lab

Cellum Biomedical INC.

Cellum Biomedical INC. was paid $1.74M by Medicaid between Oct 2020 and Oct 2024, across 5 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 76% of everything it billed.

33Billing provider infoCELLUM BIOMEDICAL INC.
TEMECULA, CA 92592
33aNPI1912522723assigned 06/08/2020
28Total paid$1.74M
24GClaims38,415
24DCodes billed5
24AFirst – last monthOct 2020 – Oct 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#153 of 561
Median peer was paid$222K
This provider vs. median7.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20201,450$85K
20219,524$432K
202220,527$930K
20235,509$246K
2024incomplete1,405$46K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 76% 19,221 6,155 $1.31M
G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source 17% 13,520 4,406 $293K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 5.7% 2,886 1,257 $99K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1.4% 580 250 $25K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,208 763 $10K

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLUCKEY, ELAINE (QA DIRECTOR)